Zacks Small Cap Research on MSN45m
TELO Study Shows Cancer-Related BreakthroughTELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback